INNOVATE Corp. Announces First Quarter 2025 Results

- Infrastructure: DBM Global first quarter revenue of $264.9 million -
- Life Sciences: MediBeacon^® Transdermal GFR (“TGFR”) System Received FDA Approval to Assess Kidney Function -
- Spectrum: Expects commercial opportunities in datacasting to generate revenue by the end of the year -

Read more at globenewswire.com